Literature DB >> 17149720

Prevalence of spinocerebellar ataxia type 2 mutation among Italian Parkinsonian patients.

Anna Modoni1, Maria Fiorella Contarino, Anna Rita Bentivoglio, Elisabetta Tabolacci, Massimo Santoro, Maria Lucia Calcagni, Pietro A Tonali, Giovanni Neri, Gabriella Silvestri.   

Abstract

We evaluated the prevalence of the SCA2 mutation among 224 Italian patients affected by typical Parkinsonism, including 145 sporadic and 79 familial forms. Pink1, Parkin, and LRRK2 gene mutations had been excluded previously. Molecular testing for the CAG expansion at the SCA 2 locus was performed on leukocyte DNA. Cloning and sequencing of the expanded allele was performed in patients positive for the SCA2 expansion. A 38 CAG expansion was detected in 1 of 79 families studied. The proband, a male age 67, and his sister, age 69, were both affected by a benign form of L-dopa-responsive Parkinsonism not associated with cerebellar signs. The inheritance was autosomal dominant. The CAG expansion was stable through meiotic transmission: sequence analysis showed that the CAG stretch was interrupted by 3 CAA. Our study shows that CAG expansion at the SCA 2 locus may represent a genetic cause of familial L-dopa-responsive Parkinsonism among Italian patients. The stability of the pathological CAG expansion detected in this family was related to the presence of CAA interruptions. These findings, together with literature data, suggest that the molecular intrinsic structure of the expanded allele may modulate the phenotypic expression of the SCA2 mutation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17149720     DOI: 10.1002/mds.21228

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  8 in total

1.  Impact of gene patents on diagnostic testing: a new patent landscaping method applied to spinocerebellar ataxia.

Authors:  Nele Berthels; Gert Matthijs; Geertrui Van Overwalle
Journal:  Eur J Hum Genet       Date:  2011-08-03       Impact factor: 4.246

Review 2.  Spinocerebellar ataxias: prospects and challenges for therapy development.

Authors:  Tetsuo Ashizawa; Gülin Öz; Henry L Paulson
Journal:  Nat Rev Neurol       Date:  2018-10       Impact factor: 42.937

3.  Psychotic-affective symptoms and multiple system atrophy expand phenotypes of spinocerebellar ataxia type 2.

Authors:  Kai-Hsiang Chen; Chin-Hsien Lin; Ruey-Meei Wu
Journal:  BMJ Case Rep       Date:  2012-03-20

4.  Repeat interruptions in spinocerebellar ataxia type 10 expansions are strongly associated with epileptic seizures.

Authors:  Karen N McFarland; Jilin Liu; Ivette Landrian; Desmond Zeng; Salmo Raskin; Mariana Moscovich; Emilia M Gatto; Adriana Ochoa; Hélio A G Teive; Astrid Rasmussen; Tetsuo Ashizawa
Journal:  Neurogenetics       Date:  2013-12-07       Impact factor: 2.660

5.  PolyQ repeat expansions in ATXN2 associated with ALS are CAA interrupted repeats.

Authors:  Zhenming Yu; Yongqing Zhu; Alice S Chen-Plotkin; Dana Clay-Falcone; Leo McCluskey; Lauren Elman; Robert G Kalb; John Q Trojanowski; Virginia M-Y Lee; Vivianna M Van Deerlin; Aaron D Gitler; Nancy M Bonini
Journal:  PLoS One       Date:  2011-03-29       Impact factor: 3.240

Review 6.  Model organisms reveal insight into human neurodegenerative disease: ataxin-2 intermediate-length polyglutamine expansions are a risk factor for ALS.

Authors:  Nancy M Bonini; Aaron D Gitler
Journal:  J Mol Neurosci       Date:  2011-06-10       Impact factor: 3.444

Review 7.  Parkinsonism in spinocerebellar ataxia.

Authors:  Hyeyoung Park; Han-Joon Kim; Beom S Jeon
Journal:  Biomed Res Int       Date:  2015-03-19       Impact factor: 3.411

8.  Consensus paper: pathological mechanisms underlying neurodegeneration in spinocerebellar ataxias.

Authors:  A Matilla-Dueñas; T Ashizawa; A Brice; S Magri; K N McFarland; M Pandolfo; S M Pulst; O Riess; D C Rubinsztein; J Schmidt; T Schmidt; D R Scoles; G Stevanin; F Taroni; B R Underwood; I Sánchez
Journal:  Cerebellum       Date:  2014-04       Impact factor: 3.847

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.